{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T12:59:22Z","timestamp":1780750762562,"version":"3.54.1"},"publisher-location":"New York, NY","reference-count":29,"publisher":"Springer US","isbn-type":[{"value":"9781071647295","type":"print"},{"value":"9781071647301","type":"electronic"}],"license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025]]},"DOI":"10.1007\/978-1-0716-4730-1_13","type":"book-chapter","created":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T13:00:08Z","timestamp":1753707608000},"page":"191-208","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["In Vivo Evaluation of Dystrophin Exon Skipping in mdx Mice"],"prefix":"10.1007","author":[{"given":"Bo","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi Long","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,29]]},"reference":[{"key":"13_CR1","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1073\/pnas.81.4.1189","volume":"81","author":"G Bulfield","year":"1984","unstructured":"Bulfield G, Siller WG, Wight PA et al (1984) X chromosome-linked muscular dystrophy (mdx) in the mouse. Proc Natl Acad Sci USA 81:1189\u20131192","journal-title":"Proc Natl Acad Sci USA"},{"key":"13_CR2","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/0092-8674(87)90579-4","volume":"51","author":"EP Hoffman","year":"1987","unstructured":"Hoffman EP, Brown RH Jr, Kunkel LM (1987) Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 51:919\u2013928","journal-title":"Cell"},{"key":"13_CR3","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1126\/science.2662404","volume":"244","author":"P Sicinski","year":"1989","unstructured":"Sicinski P, Geng Y, Ryder-Cook AS et al (1989) The molecular basis of muscular dystrophy in the mdx mouse: a point mutation. Science 244:1578\u20131580","journal-title":"Science"},{"key":"13_CR4","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1073\/pnas.98.1.42","volume":"98","author":"CJ Mann","year":"2001","unstructured":"Mann CJ, Honeyman K, Cheng AJ et al (2001) Antisense-induced exon skipping and synthesis of dystrophin in the mdx mouse. Proc Natl Acad Sci USA 98:42\u201347","journal-title":"Proc Natl Acad Sci USA"},{"key":"13_CR5","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1038\/nm897","volume":"9","author":"QL Lu","year":"2003","unstructured":"Lu QL, Mann CJ, Lou F et al (2003) Functional amounts of dystrophin produced by skipping the mutated exon in the mdx dystrophic mouse. Nat Med 9:1009\u20131014","journal-title":"Nat Med"},{"key":"13_CR6","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1126\/science.1104297","volume":"306","author":"A Goyenvalle","year":"2004","unstructured":"Goyenvalle A, Vulin A, Fougerousse F et al (2004) Rescue of dystrophic muscle through U7 snRNA-mediated exon skipping. Science 306:1796\u20131799","journal-title":"Science"},{"key":"13_CR7","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1073\/pnas.0406700102","volume":"102","author":"QL Lu","year":"2005","unstructured":"Lu QL, Rabinowitz A, Chen YC et al (2005) Systemic delivery of antisense oligoribonucleotide restores dystrophin expression in body-wide skeletal muscles. Proc Natl Acad Sci USA 102:198\u2013203","journal-title":"Proc Natl Acad Sci USA"},{"key":"13_CR8","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/nm1345","volume":"12","author":"J Alter","year":"2006","unstructured":"Alter J, Lou F, Rabinowitz A et al (2006) Systemic delivery of morpholino oligonucleotide restores dystrophin expression bodywide and improves dystrophic pathology. Nat Med 12:175\u2013177","journal-title":"Nat Med"},{"key":"13_CR9","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1038\/sj.mt.6300245","volume":"15","author":"S Fletcher","year":"2007","unstructured":"Fletcher S, Honeyman K, Fall AM et al (2007) Morpholino oligomer-mediated exon skipping averts the onset of dystrophic pathology in the mdx mouse. Mol Ther 15:1587\u20131592","journal-title":"Mol Ther"},{"key":"13_CR10","doi-asserted-by":"publisher","first-page":"14814","DOI":"10.1073\/pnas.0805676105","volume":"105","author":"B Wu","year":"2008","unstructured":"Wu B, Moulton HM, Iversen PL et al (2008) Effective rescue of dystrophin improves cardiac function in dystrophin-deficient mice by a modified morpholino oligomer. Proc Natl Acad Sci USA 105:14814\u201314819","journal-title":"Proc Natl Acad Sci USA"},{"key":"13_CR11","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/mt.2009.38","volume":"17","author":"B Wu","year":"2009","unstructured":"Wu B, Li Y, Morcos PA et al (2009) Octa-guanidine morpholino restores dystrophin expression in cardiac and skeletal muscles and ameliorates pathology in dystrophic mdx mice. Mol Ther 17:864\u2013871","journal-title":"Mol Ther"},{"key":"13_CR12","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1002\/jgm.1288","volume":"11","author":"HA Heemskerk","year":"2009","unstructured":"Heemskerk HA, de Winter CL, de Kimpe SJ et al (2009) In vivo comparison of 2\u2032-O-methyl phosphorothioate and morpholino antisense oligonucleotides for Duchenne muscular dystrophy exon skipping. J Gene Med 11:257\u2013266","journal-title":"J Gene Med"},{"key":"13_CR13","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/gt.2009.120","volume":"17","author":"B Wu","year":"2010","unstructured":"Wu B, Lu P, Benrashid E et al (2010) Dose-dependent restoration of dystrophin expression in cardiac muscle of dystrophic mice by systemically delivered morpholino. Gene Ther 17:132\u2013140","journal-title":"Gene Ther"},{"key":"13_CR14","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1038\/mt.2009.320","volume":"18","author":"Y Hu","year":"2010","unstructured":"Hu Y, Wu B, Zillmer A et al (2010) Guanine analogues enhance antisense oligonucleotide-induced exon skipping in dystrophin gene in vitro and in vivo. Mol Ther 18:812\u2013818","journal-title":"Mol Ther"},{"key":"13_CR15","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/mt.2010.288","volume":"19","author":"B Wu","year":"2011","unstructured":"Wu B, Xiao B, Cloer C et al (2011) One-year treatment of morpholino antisense oligomer improves skeletal and cardiac muscle functions in dystrophic mdx mice. Mol Ther 19:576\u2013583","journal-title":"Mol Ther"},{"key":"13_CR16","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.ajpath.2012.04.006","volume":"181","author":"B Wu","year":"2012","unstructured":"Wu B, Lu P, Cloer C et al (2012) Long-term rescue of dystrophin expression and improvement in muscle pathology and function in dystrophic mdx mice by peptide-conjugated morpholino. Am J Pathol 181:392\u2013400","journal-title":"Am J Pathol"},{"key":"13_CR17","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/mt.2012.236","volume":"21","author":"M Wang","year":"2013","unstructured":"Wang M, Wu B, Lu P et al (2013) Polyethylenimine-modified pluronics (PCMs) improve morpholino oligomer delivery in cell culture and dystrophic mdx mice. Mol Ther 21:210\u2013216","journal-title":"Mol Ther"},{"key":"13_CR18","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/gt.2014.53","volume":"21","author":"B Wu","year":"2014","unstructured":"Wu B, Cloer C, Lu P et al (2014) Exon skipping restores dystrophin expression, but fails to prevent disease progression in later stage dystrophic dko mice. Gene Ther 21:785\u2013793","journal-title":"Gene Ther"},{"key":"13_CR19","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/gt.2013.57","volume":"21","author":"M Wang","year":"2014","unstructured":"Wang M, Wu B, Lu P et al (2014) Pluronic-PEI copolymers enhance exon-skipping of 2\u2032-O-methyl phosphorothioate oligonucleotide in cell culture and dystrophic mdx mice. Gene Ther 21:52\u201359","journal-title":"Gene Ther"},{"key":"13_CR20","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1089\/hum.2013.156","volume":"25","author":"M Wang","year":"2014","unstructured":"Wang M, Wu B, Tucker JD et al (2014) Evaluation of Tris[2-(acryloyloxy)ethyl]isocyanurate cross-linked polyethylenimine as antisense morpholino oligomer delivery vehicle in cell culture and dystrophic mdx mice. Hum Gene Ther 25:419\u2013427","journal-title":"Hum Gene Ther"},{"key":"13_CR21","first-page":"261","volume":"6","author":"M Wang","year":"2015","unstructured":"Wang M, Wu B, Tucker JD et al (2015) Tris[2-(acryloyloxy)ethyl]isocyanurate cross-linked Polyethylenimine enhanced exon-skipping of antisense 2\u2032-Omethyl Phosphorothioate oligonucleotide in vitro and in vivo. J Nanomed Nanotechnol 6:261","journal-title":"J Nanomed Nanotechnol"},{"key":"13_CR22","doi-asserted-by":"publisher","first-page":"5330","DOI":"10.1039\/C5TB00139K","volume":"3","author":"M Wang","year":"2015","unstructured":"Wang M, Wu B, Tucker JD et al (2015) Tween 85 grafted PEIs enhanced delivery performance of antisense 2\u2032-O-methyl Phosphorothioate oligonucleotides in vitro and in dystrophic mdx mice. J Mater Chem B 3:5330\u20135340","journal-title":"J Mater Chem B"},{"key":"13_CR23","doi-asserted-by":"publisher","first-page":"5635","DOI":"10.2147\/IJN.S89910","volume":"10","author":"M Wang","year":"2015","unstructured":"Wang M, Wu B, Tucker JD et al (2015) Cationic polyelectrolyte-mediated delivery of antisense morpholino oligonucleotides for exon-skipping in vitro and in mdx mice. Int J Nanomedicine 10:5635\u20135646","journal-title":"Int J Nanomedicine"},{"key":"13_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/mtna.2016.51","volume":"5","author":"M Wang","year":"2016","unstructured":"Wang M, Wu B, Tucker JD et al (2016) Poly(ester amine) composed of Polyethylenimine and Pluronic enhance delivery of antisense oligonucleotides in vitro and in dystrophic mdx mice. Mol Ther Nucleic Acids 5:e341","journal-title":"Mol Ther Nucleic Acids"},{"key":"13_CR25","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1080\/10717544.2017.1337827","volume":"24","author":"M Wang","year":"2017","unstructured":"Wang M, Wu B, Shah SN et al (2017) Polyquaternium-mediated delivery of morpholino oligonucleotides for exon-skipping in vitro and in mdx mice. Drug Deliv 24:952\u2013961","journal-title":"Drug Deliv"},{"key":"13_CR26","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3390\/polym9050177","volume":"9","author":"M Wang","year":"2017","unstructured":"Wang M, Wu B, Lu P et al (2017) Evaluation of amphiphilic peptide modified antisense Morpholino oligonucleotides in vitro and in dystrophic mdx mice. Polymers 9:177","journal-title":"Polymers"},{"key":"13_CR27","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.omtn.2017.09.006","volume":"9","author":"M Wang","year":"2017","unstructured":"Wang M, Wu B, Tucker JD et al (2017) Tween 85 modified low molecular weight Polyethylenimine enhances exon-skipping of antisense Morpholino oligomer in vitro and in mdx mice. Mol Ther Nucleic Acids 9:120\u2013131","journal-title":"Mol Ther Nucleic Acids"},{"issue":"12","key":"13_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0278482","volume":"17","author":"B Wu","year":"2022","unstructured":"Wu B, Drains M, Shah SN, Lu P, Leroy V, Killilee J, Rawls R, Tucker JD, Blaeser A, Lu Q (2022) Ribitol dose-dependently enhances matriglycan expression and improves muscle function with prolonged life span in limb girdle muscular dystrophy 2I mouse model. PLoS One 17(12):e0278482","journal-title":"PLoS One"},{"key":"13_CR29","doi-asserted-by":"crossref","unstructured":"Wu B, Benrashid E, Lu P, Cloer C, Zillmer A, Shaban M, Lu QL (2011) Targeted skipping of human dystrophin exons in transgenic mouse model systemically for antisense drug development. PLoS One 6(5):e19906","DOI":"10.1371\/journal.pone.0019906"}],"container-title":["Methods in Molecular Biology","Exon Skipping and Inclusion Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-4730-1_13","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T12:05:00Z","timestamp":1780747500000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-4730-1_13"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"ISBN":["9781071647295","9781071647301"],"references-count":29,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-4730-1_13","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"29 July 2025","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}